Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$51,448,133
-$25,435,798 QoQ
Shares Held
170,907
-26.5% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#78
of 780 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Man Group plc holds $1,094,353,895 across 113 Biotechnology names. ALNY ranks #6 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
436,956 | $272,459,544 | |
| 2 | INCY |
Incyte Corp
|
952,941 | $108,025,391 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
307,463 | $87,617,731 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
139,233 | $69,161,207 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
397,000 | $52,693,809 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
170,907 | $51,448,133 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
152,877 | $36,838,770 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
173,439 | $32,481,655 |
All Filings in ALNY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,448,133 | 170,907 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $76,883,931 | 232,369 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $57,345,106 | 144,210 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $32,682,888 | 71,673 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,644,262 | 8,109 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,909,311 | 7,071 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,854,848 | 16,382 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $30,199,118 | 109,803 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $28,652,130 | 117,910 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $31,419,619 | 210,235 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $8,209,574 | 42,890 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,594,420 | 20,296 | Principal | Defined | 2023-11-14 | |
| 2023-06-30 | $9,625,967 | 50,679 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $26,276,975 | 131,175 | Principal | Defined | 2023-05-15 | |
| 2022-12-31 | $437,512 | 1,841 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $263,810 | 1,318 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,034,239 | 61,942 | Principal | Defined | 2022-08-15 | |
| 2022-03-31 | $224,360 | 1,374 | Shares | Defined | 2022-05-16 | |
| 2021-09-30 | $650,072 | 3,443 | Shares | Defined | 2021-11-15 | |
| 2020-12-31 | $2,598,359 | 19,992 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,190,532 | 21,913 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $8,721,309 | 58,884 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $293,895 | 2,700 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||